(Q73595223)

English

Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively

scientific article published on 01 April 2000

In more languages
default for all languages
No label defined

No description defined

Statements

Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit